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Background: Intermedin (IMD) is a novel member of the calcitonin/calcitonin gene-related peptide family.
Endoplasmic reticulum stress (ERS) has been implicated in the pathology of renal ischemia/reperfusion (IRI). In the
present study, we investigated whether IMD could reduce ERS damage after renal ischemia.
Methods: The kidneys of SD rats were subjected to 45 min of warm ischemia followed by 24 h of reperfusion. The
hypoxia/reoxygenation(H/R) model in NRK-52E cells consisted of hypoxia for 1 h and reoxygenation for 2 h. IMD
was over-expressed in vivo and in vitro using the vector pcDNA3.1-IMD. The serum creatinine concentration and
lactate dehydrogenase (LDH) activity in the plasma were determined. Histologic examinations of renal tissues were
performed with PAS staining. Real-time PCR and Western blotting were used to determine the mRNA and protein
levels, respectively. Additionally, ER staining was used to detect the ERS response.
Results: In the rat renal IRI model, we found that IMD gene transfer markedly improved renal function and
pathology and decreased LDH activity and cell apoptosis compared with the kidneys that were transfected with
the control plasmid. IMD significantly attenuated the ERS stress parameters compared with IRI group. Indeed, IMD
down-regulated glucose-regulated protein 78 (GRP78), C/EBP homologous protein(CHOP), and caspase 12 protein
and mRNA levels. Moreover, in the NRK-52E cell H/R model, IMD overexpression prevented the apoptosis induced
by H/R. Furthermore, IMD ameliorated the ER structural changes and concomitantly decreased the levels of GRP78,
CHOP and caspase-12.
Conclusion: This study revealed that IMD protects against renal IRI by suppressing ERS and ERS-related apoptosis.
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Renal ischemia-reperfusion injury (IRI) is a general
health problem and the most common cause of acute
kidney injury (AKI) [1–3]. IRI affects both native and
transplanted kidneys and is associated with high morbid-
ity and mortality [4]. Evidence has shown that many fac-
tors, including reactive oxygen species (ROS), abnormal
protein synthesis, Ca2+ overload and apoptosis, are in-
volved in the development of renal IRI [5].* Correspondence: rongshanli13@163.com
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endoplasmic reticulum stress (ERS) as a major contribu-
tor to the increase in apoptosis and the exacerbation of
cell damage after IRI [6, 7]. The ER is the principal site
of protein synthesis and folding, Ca2+ storage, and sig-
naling. Various stimuli, such as ER Ca2+ overload, ele-
vated protein synthesis, ischemia, and hypoxia, interact
with ER homeostasis and result in ERS [8]. Moreover,
excessive and/or prolonged ERS triggers the apoptotic
death program [9]. ERS is considered to be an early or
initial response of cells that are stressed or damaged and
occurs extensively in the pathophysiology of renal IRI
[10–12]. Thus, ERS causes cell damage and apoptosis,
but the inhibition or remodeling of the ERS responseis distributed under the terms of the Creative Commons Attribution 4.0
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strategy for renal H/R and IRI injury.
Intermedin/adrenomedullin-2 (IMD/ADM2) is a novel
member of the calcitonin gene-related peptide (CGRP)
family and is distributed in a wide variety of tissues, in-
cluding brain, heart, lung, gastrointestinal tract, pituit-
ary, and kidney tissues [13, 14]. IMD is considered to be
potential endogenous protective agent in the heart, vascu-
lar system, and kidneys [15, 16]. Our previous investiga-
tions demonstrated that IMD gene transfer significantly
reduces renal ischemia/reperfusion injury by inhibiting
oxidative stress, ameliorating inflammation and promoting
renal cell proliferation and regeneration [17, 18]. It has
been reported that IMD can protect against myocardial
IRI by inhibiting myocardial ERS, and the phosphoinosi-
tide 3-kinase/Akt(PI3K/Akt) signaling pathway is involved
in this inhibitory effect [19]. However, the detailed mech-
anism by which IMD protects against renal IRI and the as-
sociation of this protective effect with ERS have not been
investigated. Therefore, the aim of this study was to inves-
tigate whether IMD protects against renal IRI by inhibit-
ing ERS in incubated rat tubular epithelial cells in vitro
and in a rat renal IRI model.
Methods
Ultrasound-mediated gene delivery into the kidney
The eukaryotic expression plasmid pcDNA3.1-IMD con-
taining full-length cDNA sequence of rat IMD was cre-
ated according to the methods described in our previous
study [20]. Ten minutes after the removal of the right
kidney, the pcDNA3.1-IMD plasmid or an empty control
vector(pcDNA3.1) was transfected into the left kidney
via the renal artery using an ultrasound-mediated system
as described in our previous study [18].
Animals
All male SD rats (180–200 g) were purchased from the
Experimental Animal Center of Shanxi Medical Univer-
sity (Taiyuan, China) and maintained in a specific
pathogen-free environment in our facility. All animals
were fed with standard chow and had free access to
water. All animal experiments were performed in a hu-
mane manner, and also in accordance with the Institu-
tional Animal Care Instructions. This study was
conducted under experimental protocols approved by
the Ethics Committee for Animals, Shanxi Medical
University.
Renal IRI model and experiment design
The animals were randomly divided into the following
four groups: sham, IRI, IRI + IMD, and IRI + empty plas-
mid. The renal IRI model was created by clamping the
left renal artery with a non-traumatic vascular clamp for
45 min 1 week after the removal of the right kidney. Theclamp was then removed, the kidney was observed for
the return of blood flow, and the incision was sutured.
The sham rats were underwent a similar procedure
without the occlusion of the renal artery. The IRI + IMD
rats and IRI + empty plasmid rats were treated with
ultrasound as described above 1 week before renal IRI.
The rats were killed 24- h after reperfusion. Blood and
kidney samples were collected and submitted to the cor-
responding examinations.
Measurements of renal function and LDH activity
Renal function was assessed by measuring the serum
creatinine concentrations, and the LDH activity was
assessed with a commercially available colorimetric
method (Nanjing Jiancheng Bioengineering Institute,
Nanjing, P.R. China). These experiments were performed
at least three times.
Histological examination
After fixation with 10 % paraformaldehyde, paraffin-
embedded transverse kidney slices were sectioned at
3 μm and stained with Periodic Acid-Schiff (PAS) stain.
The histopathological scoring was performed by an ex-
perienced pathologist who was unaware of the treat-
ment. The scores were given based on gradings of the
tubular necrosis, nuclear pyknosis, cast formation, and
tubular dilatation and interstitial infiltration in the outer
medulla of 10 randomly chosen, non-overlapping fields
(400×), and the mean of all of the scores was used for
the comparisons between the groups. The morpho-
logic changes were scored semiquantitatively on a 0
to 5+ scale (0, no lesion; 1+, <10 % of parenchyma
affected by the lesion; 2+, 11–25 % of parenchyma af-
fected by the lesion; 3+, >26–45 % of parenchyma af-
fected by the lesion; and 4, >46–75 % of parenchyma
affected by the lesion,; and 5, >76 % of parenchyma
affected by the lesion).
TUNEL assay
To detect tubular cell apoptosis, a terminal deoxynu-
cleotidyl transferase dUTP nick-end labeling (TUNEL)
apoptosis detection kit (Roche, Mannheim, Germany)
was used. Briefly, each slide was deparaffinized and rehy-
drated, and treated with proteinase K (20 mg/L) for
15 min. The endogenous peroxidase was inhibited with
3 % hydrogen peroxide for 5 min, and then incubated
with the TUNEL reaction mixture containing terminal
deoxynucleotidyl transferase (TdT) and digoxigenin-11-
dUTP for 1 h. The TdT reaction was carried out in a hu-
midified chamber at 37 °C, and then 3,3-diaminobenzi-
dine chromogen was applied. Hematoxylin was used as
counterstaining. Apoptotic cell death was quantitatively
analyzed by counting the TUNEL-positive cells selected
randomly from 10 fields, at 400× magnification. The
Table 1 Primers for real-time PCR
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averaged.
Cell culture and treatments
The rat tubular epithelial cell line NRK-52E was ob-
tained from the Cell Bank of the Chinese Academy of
Sciences (Shanghai, China). The cells were cultured in
DMEM/Ham’s F-12 (2:1) containing with 100 u/ml peni-
cillin—streptomycin, 10 % fetal bovine serum and incu-
bated at 37 °C, room air with 5 % CO2 . The cells were
seeded in 6-well plates until they reached approximately
80 % confluence. The over-expression of IMD in the
NRK-52E cells that were transfected with pcDNA3.1-
IMD was accomplished according to the methods de-
scribed in our previous study [20]. The model of H/R in-
jury in the NRK-52E cells was established in an
incubator as described previously [21]. In brief, the cells
were washed with DMEM/F12 and then incubated in
modified Tyrode’s solution [22] with 95 % N2 + 5 % CO2
for 1 h (hypoxia). Reoxygenation was achieved by
switching the medium to fresh DMEM/F12, and the
cells were subsequently maintained in 95 % air-5 % CO2
for 2 h. The cells were assigned to 1 of 5 groups: control
(untreated NRK-52E cells); tunicamycin (Tm) (NRK-52E
cells were incubated with Tm (10 mg/ml, Sigma, USA)
for 30 min); H/R (the cells were exposed to 1 h of hyp-
oxia and 2 h of reoxygenation); H/R + pcDNA3.1 (NRK-
52E cells were transfected with the empty plasmid
pcDNA3.1 prior to H/R); and H/R + IMD (IMD was
overexpressed in NRK-52E cells exposed to H/R).
Determination of apoptosis in NRK-52E cells
The apoptosis of the NRK-52E cells was measured by
flow cytometry (FCM) with a FITC Annexin V Apop-
tosis Detection Kit I (BD Pharmingen TM, New Jersey,
USA) according to the manufacturer’s instructions. The
apoptosis ratio (%) was the ratio of the sum of the cells
that stained positive for Annexin V-FITC plus the cells
that stained positive for both Annexin V-FITC and PI
divided by the entire population of cells.
ER staining
The cells were plated on glass-bottom culture dishes
and subjected to different treatments. The ER staining
was performed according to the protocol from the kit
(GMS10041.2, Genmed, Arlington, MA). The presence
of ER staining was visualized under a confocal immuno-
fluorescence microscope (Olympus, Japan).
Semiquantitative RT-PCR
Total renal RNA was extracted with Trizol reagent (Invi-
trogen, Carlsbad, CA). First-strand cDNA was synthesized
using oligo dT primers and reverse transcription was per-
formed according to the manufacturer’s instructions usingM-MLV reverse transcriptase (TaKaRa Biotechnology Co.,
Ltd., Dalian, China) with total RNA as a template. RT-
PCR was performed using a RT-PCR Kit following the
manufacturer’s instruction (TaKaRa Biotechnology
Co., Ltd., Dalian,China). The 25 -μl reaction volume
containing 2.5 μl 10 × PCR buffer, 4.0 μl dNTP, 1.0 μl
each primer, 0.25 μl Taq polymerase and 2.0 μl cDNA
mix. PCR was initiated with a denaturation step at
94 °C for 3.0 min, followed by 30 cycles of amplifica-
tion (94 °C for 30 s, 54 °C for 30 s, and 72 °C for
1.0 min), and a final step at 72 °C for 10 min. The
PCR produced was separated using 1.0 % agarose gel.
The specific primers were used for rat IMD (sense:
5′-GGAAATCGTGCGTGACATTAAG-3′ and anti-
sense: 5 ′-GGACTCGTCATACTCCTGCTTG-3′) and
β-actin (sense: 5′-CCTCACTTCGGCCTGTAGTT-3′
and antisense: 5′ -ACCCACCTCAGCCATAACTT-3′).
Reverse transcription polymerase chain reaction and real-
time polymerase chain reaction
Total RNA was isolated using Trizol (TAKARA, Dalian,
China). Complementary DNA (cDNA) was obtained
from total the RNA using the SuperScript First-Strand
synthesis system RT-PCR kit (TAKARA, Dalian, China).
qPCR amplifications were performed in triplicate using
the SYBR Green I assay and the Stratagene M3000 Se-
quence Detection System (Stratagene, USA). The gene
sequences were identified in GenBank to design the spe-
cific primers (Table 1). The reactions were performed in
96-well plates in 20-μl reaction volumes in the following
conditions: 95 °C for 5 min, followed by 40 cycles of 95 °C
for 5 s and 60 °C for 30 s. In each assay, a standard curve
was determined concurrently with the examination of the
samples. Gene expression was quantified using a modifica-
tion of the 2-ΔΔct method. All PCR reactions were per-
formed in triplicate.
Western blot analysis
The cortical tissues of the rats’ kidneys and cell lysates
were extracted in lysis buffer (KeyGEN Biotech, Nanjing,
China). Equal amounts of protein (50 μg) as determined
Fig. 1 The transfection efficiency of IMD by ultrasound-mediated gene delivery into the Kidney in vivo and by FuGENE HD into NRK-52E cells
in vitro. a Representative IMD protein expression measured by Western blot in rats, (b) representative IMD protein expression measured by
Western blot in NRK-52E cells, (c) Quantitative analysis of IMD by Western blots in rats, (d) Quantitative analysis of IMD by Western blots in NRK-
52E cells, (e) representative IMD mRNA expression measured by RT-PCR in rats, (f) representative IMD mRNA expression measured by RT-PCR in
NRK-52E cells, (g) densitometric quantifications of band intensities from RT-PCR for IMD/β-actin in rats, (h) densitometric quantifications of band
intensities from RT-PCR for IMD/β-actin in NRK-52E cells. M: DL500 DNA marker, Data in bar graphs are means ± SD, n = 6.* P < 0.05 vs. sham
group or control group; # P < 0.05 vs. IRI group or H/R group, respectively
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China) were separated on 10 % SDS-polyacrylamide gels
and electrophoretically transferred to a nitrocellulose fil-
ter membrane (Millipore, Bedford, MA). After incuba-
tion with 5 % bovine serum albumin (BSA, dissolved in
PBS) for 2 h at room temperature and blocking of the
non-specific binding, the membranes were incubated
overnight at 4 °C with primary antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA) at dilution of 1:1000–
5000. Then, the fluorescein-linked secondary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) was addedFig. 2 IMD ameliorated renal injury in rats after IRI treatment. a Serum crea
groups. c - f Renal pathomorphological changes after renal ischemia-reperf
groups, (e) IRI + empty plasmid groups, (f) IRI + IMD groups, Magnification:×
grading system. Data in bar graphs are means ± SD, n = 8. * P < 0.05, **P <at a dilution of 1:3000 to the membrane and incubated
at room temperature for 2 h. The specific bands were vi-
sualized by fluorography using an enhanced chemilu-
minescence kit (Pierce, Rockford, USA). The relative
density was quantified using the Quantity One analysis
system (Bio-Rad, California, USA).Statistical analysis
The data are expressed as the means ± the SDs. Significant
differences between groups were assessed by one-waytinine concentration, (b) the LDH activity in different IRI treatment
usion injury (IRI), Original magnification, ×400; (c) Sham groups, (e) IRI
400 (g) semiquantitation of the morphological changes by histological
0.01 vs. sham group; # P < 0.05, ## P < 0.01 vs. IRI group, respectively
Wang et al. BMC Nephrology  (2015) 16:169 Page 6 of 12ANOVA with Student-Newman-Keuls post hoc tests.
P values < 0.05 were considered statistically significant.
Results
The transfection efficiency of IMD by ultrasound-
mediated gene delivery into the Kidney in vivo and by
FuGENE HD into NRK-52E cells in vitro
To determine the efficacy of ultrasound-microbubble-
mediated gene transfection in kidney and by FuGENE
HD in NRK-52E cells in vitro, we examined theFig. 3 IMD suppressed cell apoptosis triggered by renal IRI. a - d Determina
transferase biotin-dUTP nick end-labeling (TUNEL) assay. (×200) (a) Sham g
groups, Magnification:×400 (e) Determination of positive tubular cells in th
sham group; ## P < 0.01 vs. IRI groupexpression of IMD in kidneys and NRK-52E cells with
semiquantitative RT-PCR and Western blot analysis. As
shown in Fig. 1, after 7 days of transfection, kidneys
from rats treated with pcDNA3.1-IMD plasmid exhib-
ited significant increase in IMD expression compared
with kidneys of rats treated with control empty vector ,
and the expression of IMD in NRK-52E cells transfected
with pcDNA3.1-IMD plasmid was much high than in
controls, indicating that IMD was transfected into the
kidney and NRK-52E cells successfully.tion of tubular cell apoptosis in situ by terminal deoxynu-cleotidyl
roups, (b) IRI groups, (c) IRI + empty plasmid groups, (d) IRI + IMD
e TUNEL assay. Data in bar graphs are means ± SD, n = 8. **P < 0.01 vs.
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treatment
As shown in Fig. 2, renal IRI resulted in a significant
increases in plasma Cr levels (1.52 ± 0.24 mg/dl l vs.
0.71 ± 0.09 mg/d, P < 0.01) and LDH activity (805.17 ±
35.12 U/L vs. 114.21 ± 12.15 U/L, P <0.01) compared
with the sham group. The over-expression of IMD
elicited significant improvements in cells integrity and
reductions in renal functional injury compared with
the IRI group (P <0.05). On light microscopy, theFig. 4 Effects of IMD on markers of endoplasmic reticulum stress (ERS) in IR
12, and β-actin as a control; Quantitative analysis of (b) GRP78, (c) CHOP, a
GRP78, CHOP and caspase-12 were determined by real time-PCR. Data in b
P < 0.05, ## P < 0.01 vs. IRI group, respectivelyPAS staining revealed that there were severe patho-
logical changes in the kidneys with renal IRI that in-
cluded a loss of the brush-border membranes, tubular
dilatation, flattened tubular epithelia, cast formation,
luminal debris, and interstitial infiltration (Fig. 2d). In
contrast, the overexpression of IMD significantly
attenuated these pathological renal abnormalities
(Fig. 2f ). In the kidneys transfected with the empty
vector, the levels of serum Cr, LDH and the patho-
logical changes exhibited no significant differencesI rats. a Representative protein expression of GRP78, CHOP, caspase-
nd (d) caspase-12 by Western blots. e The mRNA expression levels of
ar graphs are means ± SD, n = 8. * P < 0.05, **P < 0.01 vs. sham group; #
Fig. 5 IMD inhibited ERS-related apoptosis in NRK-52E cell of H/R injury. a - e Cell apoptosis measured by flow cytometry. a control, b Tm, c H/R,
d H/R + pcDNA3.1, e H/R + IMD, f The apoptosis ratio in different H/R treatment groups. g ER morphology (blue) in NRK-52E cells loaded with
Dapoxyl according to the kit. Data in bar graphs are means ± SD, n = 6. **P < 0.01 vs. control group; ## P < 0.01 vs. Tm or H/R group, respectively
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group. This result indicated that the improved kidney
function and renal pathological changes in rats was
due to the overexpression of IMD.
IMD suppressed cell death triggered by renal IRI
The cell death in the rat kidneys following IRI were
assessed using a TUNEL assay. Our results indicated
that the TUNEL‑positive renal tubular epithelial cells
were significantly more numerous in the IRI group
than in the sham group (31.5 ± 5.46 % vs. 3.95 ±
0.89 %, P < 0.01, Fig. 3). However, a significant reduc-
tion in the number of death tubular cells in the kid-
ney was detected in the IRI + IMD group (20.99 ±
4.32 %). These results suggested that IMD suppressed
tubular cell death and thereby protected the kidney
from renal IRI.
IMD reduced ERS stimulated by renal IRI
Several studies have evidenced the pivotal role of ERS as
a major contributor to the increase in apoptosis and the
exacerbation of cell damage following IRI. We per-
formed western blot and realtime PCR and found that
renal IRI caused a robust enhancements of GRP78,
CHOP, and caspase 12, compared with the sham group(-
all P <0.01, Fig. 4), and these changes were indicative of
ERS. The overexpression of IMD significantly reduced
the GRP78 level (P < 0.05). Similarly, this treatment sig-
nificantly reduced the relative amounts of CHOP and
caspase 12 (P < 0.05) compared to IRI alone. As a con-
trol, the empty plasmid did not improve the ERS param-
eters compared to IRI group; the parameters of both of
these groups remained high compared to those of the
sham group (P <0.01). These results suggested that the
protective effects of IMD may have been mediated by
the repression of ERS.
IMD inhibited ERS-related apoptosis in the NRK-52E cells
with H/R injury
To determine whether IMD had a direct inhibitory effect
on renal ERS, the ERS-inducer Tm (10 mg/ml) was in-
cubated with the rat tubular epithelial NRK-52E cells
line in vitro. We assessed cell apoptosis using a flow cy-
tometry assay. As shown in Fig. 5a - f, the apoptosis ac-
tivity ratios were significantly higher in H/R and Tm
groups than in the control group. The ER staining in the
fresh viable NRK-52E cells (Fig. 5g) demonstrated that
the structure of the ER was severely destroyed in the
NRK-52E cells subjected to H/R treatment. The fluores-
cence density revealed a non-uniform distribution that
was accompanied by notable vacuoles in the ER. More-
over, there were no significant differences between the
H/R and Tm groups in any of these results. Therefore,
we suggest that H/R and Tm were equally effective ininducing ERS-related apoptosis. Compared to the H/R
group, the over-expression of IMD significantly reduced
the number of apoptotic tubular cells among the NRK-
52E cells. ER staining also demonstrated that the IMD
treatment significantly attenuated the injury to the ER.
Compared with the control group, H/R and Tm treat-
ment significantly upregulated the protein expressions of
GRP78, CHOP, and caspase-12 (all P < 0.05) and IMD at-
tenuated the upregulated expression of the H/R-induced
overexpressions of the ERS marker proteins (all P < 0.05;
Fig. 6a–d). The mRNA expressions of GRP78, CHOP
and caspase-12 confirmed these results (Fig. 6e).
Discussion
In the present study, we showed that the overexpression
of IMD can ameliorate the renal dysfunction and protect
against the renal damage caused by IRI. Moreover, IRI
can up-regulate the expression of ERS markers, such as
GRP78, CHOP and caspase 12, and induce ERS-related
apoptosis. Our data suggest that the protective effects of
IMD in renal IRI were primarily mediated through the
inhibition of ERS and ERS-related apoptosis.
Intermedin (IMD), also called adrenomedullin 2 (ADM-
2), is a novel member of the calcitonin gene-related pep-
tide (CGRP) superfamily [13, 14] and has been shown to
have pathophysiological effects in multiple disease pro-
cesses involving the circulatory and renal systems [15, 16,
23, 24]. Recently, we showed that IMD gene transfer sig-
nificantly reduces renal ischemia/reperfusion injury appar-
ently by reducing oxidative stress and promoting renal
tubular cell proliferation and regeneration after renal cell
H/R injury [17, 18].
Our results revealed that the overexpression of IMD
in the kidney significantly improved renal function, pro-
tected against the renal damage caused by IRI, and at-
tenuated renal pathological abnormalities. Moreover, the
results of our TUNEL assay revealed that the rate of
apoptosis among the renal tubular cells was lower in the
IMD + IRI group than in the IRI group. These results
suggest that IMD protected the kidneys of the rats in
the IRI model by improving their structures and func-
tions and inhibiting cell apoptosis.
Renal tubule epithelial cell apoptosis induced by IRI is
the main cause of the development and progression of
AKI [25, 26]. Some recent evidence strongly suggests
that renal IRI induces ERS and that the involvement of
ERS is an initiator of cell death during ischemic glom-
erular and tubular epithelial injury following renal IRI
[27, 28]. The ER is one of the largest organelles in the
cell and plays an important role in the regulation of cel-
lular homeostasis. The ER is responsible for the synthe-
sis, modification, and processing of proteins, the chain
folding, assembly, and transportation of new peptides,
the biosynthesis of steroids, cholesterol, and many lipids,
Fig. 6 IMD inhibited tunicamycin (Tm) and H/R-induced (ERS) in vitro. a Representative protein expression of GRP78, CHOP, caspase-12, and
β-actin as a control; Quantitative analysis of (b) GRP78, (c) CHOP, and (d) caspase-12 by Western blots. e The mRNA expression levels of GRP78,
caspase-12, CHOP were determined by real time-PCR. Data in bar graphs are means ± SD, n = 6. * P < 0.05, **P < 0.01 vs. control group; # P < 0.05
vs. Tm or H/R group, respectively
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sults can interfere with this machinery and cause aber-
rant protein folding. The accumulation of unfolded or
misfolded proteins in the ER lumen induces ERS, which
in turn activates a well-conserved adaptive response
[29–31]. However, when ERS is excessive or severe,
these adaptive responses are not sufficient to relieve the
ERS, and cell apoptosis is induced through the activation
of a signaling pathway, such as the C/EBP homologous
protein (CHOP), caspase-12, or JNK signaling pathway
[32, 33]. In the physiological state, glucose-regulated
protein 78 (GRP78) binds to the effectors of UPR to sup-
press their activities [34]. Under conditions of ER stress,
when misfolded proteins accumulate in the ER lumen,
GRP78 dissociates from these effectors and allows their
activations [35]. Under physiological conditions, these
mediators are inactivated by binding to GRP78 in the ER
membrane, and GRP78 dissociates from these effectors
and allows their activations [36]. When IRI-induced ERS
is too severe to overcome, UPR gradually develops into
the apoptotic phase. CHOP accumulation, IRE1 phos-
phorylation and JNK activation initiate the apoptotic
phase and finally lead to cell apoptosis in renal IRI [37–
40]. Thus, GRP78, CHOP and caspase-12 are generally
considered to be strong markers of the ERS level [19].
To confirm the effect of IMD on ERS, we detected the
levels of these markers of ERS (i.e., GRP78, CHOP and
caspase-12) in a rat renal IRI model. The results revealed
that the mRNA and protein expression levels of GRP78,
CHOP and caspase-12 in the kidney were significantly
increased in the IRI rats and that IMD treatment sig-
nificantly inhibited the increased levels of the renal
ERS factors and ERS-induced renal injury and apop-
tosis. Additionally, we used the specific ERS inducer
Tm [41] to induce ERS in vitro in the rat tubular epi-
thelial cell line NRK-52E. Our flow cytometry assay
and ER staining results confirmed that the apoptosis
rates were elevated and that the structure of the ER
was severely destroyed in the NRK-52E cells in the
Tm and in vitro H/R groups. Moreover, the overex-
pression of IMD attenuated the rates of apoptosis and
improved the ER structures. Moreover, the Tm and
H/R groups also exhibited upregulations of the ERS
markers GRP78, CHOP and caspase-12, and IMD
inhibited these upregulations. Therefore, the protect-
ive effects of IMD against renal injury were mediated,
at least in part, by the inhibition of renal ERS.Conclusion
Our study findings indicate that the overexpression of
IMD in the kidney protects against renal IRI apparently
by reducing ERS and consequently suppressing ERS-
induced apoptosis. Thus, IMD might be a new target forthe inhibition of ERS and the improvement of renal
function in ischemia-mediated acute renal failure.
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